Marco Mastrodonato
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
Marco Mastrodonato is the founder of BMG Pharma SpA, serving as Chief Executive Officer since 2011.
Mr. Mastrodonato is the founder of Lobe Sciences Ltd., serving as Director since 2025.
Formerly, Mr. Mastrodonato worked at Sinclair Pharma Plc as Executive Vice President from 2001 to 2011.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LOBE SCIENCES LTD -.--% | 01/09/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LOBE SCIENCES LTD. | Directeur/Membre du Conseil | 08/09/2025 |
BMG Pharma SpA
BMG Pharma SpA Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products and aesthetic medicines | Directeur Général | 01/01/2011 |
| Sociétés | Poste | Fin |
|---|---|---|
Sinclair Pharma Plc /Old/
Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Develops and wholesales pharmaceutical products | Corporate Officer/Principal | 27/06/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Sinclair Pharma Plc /Old/
Sinclair Pharma Plc /Old/ Pharmaceuticals: MajorHealth Technology Develops and wholesales pharmaceutical products | Health Technology |
BMG Pharma SpA
BMG Pharma SpA Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products and aesthetic medicines | Health Technology |
Lobe Sciences Ltd.
Lobe Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops patented drug candidates to treat chronic cluster headache | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national